1p/19q chromosome deletions in metastatic oligodendroglioma

Journal of Neuro-Oncology

Volumn 80, Issue 2, 2006, Pages 203-207

  Merrell, Ryan ^a   Nabors, L Burton ^a   Perry, Arie ^b   Palmer, Cheryl Ann ^a,c  

^a The University of Alabama at Birmingham   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

1p 19q; Chromosome deletions; Metastatic oligodendroglioma; Oligodendroglial neoplasms

Indexed keywords

ANTICONVULSIVE AGENT; CISPLATIN; CORTICOSTEROID DERIVATIVE; ETOPOSIDE; LANSOPRAZOLE; LOMUSTINE; PROCARBAZINE; ROFECOXIB; TAMOXIFEN; VINCRISTINE;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD TRANSFUSION; BONE BIOPSY; BONE MARROW SUPPRESSION; BONE METASTASIS; BONE SCINTISCANNING; CASE REPORT; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME ANALYSIS; CHROMOSOME ARM; CHROMOSOME DELETION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CRANIOTOMY; DEATH; DRUG SUBSTITUTION; ERYTHROCYTE TRANSFUSION; FEMALE; FEMUR TUMOR; FOLLOW UP; GENETIC ANALYSIS; HEADACHE; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; HUMAN TISSUE; HUMERUS; INFECTION; LUMBAR SPINE; MALE; MENINGIOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; PANCYTOPENIA; RADIODIAGNOSIS; RIB; SEIZURE; SKULL TUMOR; SPINAL CORD COMPRESSION; SPINE TUMOR; SYSTEMIC DISEASE; THROMBOCYTOPENIA; TIBIA; TUMOR RECURRENCE;

ADULT; AGED; BONE MARROW NEOPLASMS; BONE NEOPLASMS; BRAIN NEOPLASMS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 19; FATAL OUTCOME; FEMALE; HUMANS; IN SITU HYBRIDIZATION; MAGNETIC RESONANCE IMAGING; MALE; OLIGODENDROGLIOMA; SPINAL NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33750297475     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-006-9179-0     Document Type: Article

References (18)

1. Engelhard HH, Stelea A, Mundt A (2003) Oligodendroglioma and anaplastic oligodendroglioma: Clinical features, treatment, and prognosis. Surg Neurol 60(5):443-456
2. Jukich PJ, McCarthy BJ, Surawicz TS, Freels S, Davis FG (2001) Trends in incidence of primary brain tumors in the United States, 1985-1994. Neuro-oncology 3:959-966
3. Fortin D, Macdonald DR, Stitt L, Cairncross JG (2001) PCV for oligodendroglial tumors: In search of prognostic factors for response and survival. Can J Neurol Sci 28:215-223
4. Chahlavi A, Kanner A, Peereboom D, Staugaitas SM, Elson P, Barnett G (2003) Impact of chromosome 1p status in response of oligodendroglioma to temozolomide: Preliminary results. J Neurooncol 61:267-273
5. Morrison T, Bilbao JM, Guisheng Y, Perry JR (2004) Bony metastasis of anaplastic oligodendroglioma respond to temozolomide. Can J Neurol Sci 31:102-118
6. Liwnicz BH, Rubinstein LJ (1979) The pathways of extraneural spread in metastasizing gliomas: A report of three cases and critical review of the literature. Hum Pathol 10:453-467
7. Macdonald DR, O'Brien RA, Gilbert JJ, Cairncross JG (1989) Metastatic anaplastic oligodendroglioma. Neurology 39:1593-1596
8. Dawson TP (1997) Pancytopenia from a disseminated anaplastic oligodendroglioma. Neuropathol Appl Neurobiol 23:516-520
9. Perry A (2004) News in brief. metastatic oligodendroglioma: A mini-epidemic? Adv Anat Pathol 11:325
10. Cairncross JG, Ueki K, Zlatescu C, Lisle DK, Finkelstein DM, Hammond RR, Silver JS, Stark PC, Macdonald DR, Ino Y, Ramsay DA, Louis DN (1998) Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendroglioma. J Natl Cancer Inst 90(19):1473-1479
11. Ino Y, Betensky RA, Zlatescu C, Sasaki H, Macdonald DR, Stemmer-Rachamimov AO, Ramsay DA, Cairncross JG, Louis DN (2001) Molecular subtypes of anaplastic oligodendroglioma: Implications for patient management at diagnosis. Clin Cancer Res 7:839-845
12. Giordana MT, Ghimenti C, Leonardo E, Balteri I, Iudicello M, Duo D (2004) Molecular genetic study of a metastatic oligodendroglioma. J Neurooncol 66:265-271
13. Fallon KB, Palmer CA, Roth K, Nabors LB, Wang W, Carpenter M, Banerjee R, Forsyth P, Rich K, Perry A (2004) Prognostic value of 1p, 19q, 9p, 10q and EGFR-FISH analyses in recurrent oligodendrogliomas. J Neuropathol Exp Neurol 63:314-322
14. Perry A, Fuller CE, Banerjee R, Brat DJ, Scheithauer BW (2003) Ancillary FISH analysis for 1p and 19q status: Preliminary observations in 287 gliomas and oligodendroglioma mimics. Front Biosci 8:a1-a9
15. Bigner DD, McLendon RE, Brunner JM (1998) Russell & Rubinstein's pathology of tumors of the nervous system. 6th edn. Edward Arnold, London, pp518-522
16. Ho-Keung N, Sun D, Poon W (2001) Anaplastic oligodendroglioma with drop metastasis to the spinal cord. Clin Neuro Neurosurg 104:383-386
17. Smith JS, Perry A, Borell TJ, Lee HK, O'Fallon J, Hosek SM, Kimmel D, Yates A, Burger PC, Scheithauer BW, Jenkins RB (2000) Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 18:636-645
18. Anand M, Kumar R, Paresh J, Gupta R, Ghosal N, Sharma A, Agarwal A, Sharma MC (2003) Metastatic anaplastic oligodendroglioma simulating acute leukemia. Acta Cytol 47:467-469